DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Robertson JFR, Bondarenko IM, Trishkina E. et al.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Lancet 2016;
388: 2997-3005
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.